Telazorlimab Uses, Dosage, Side Effects and more
Telazorlimab is under investigation in clinical trial NCT03568162 (Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis).
| Trade Name | Telazorlimab |
| Generic | Telazorlimab |
| Telazorlimab Other Names | Telazorlimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
